Najmi Amir Hossein, Ariaei Armin, Khezri Mahboobeh, Noroozi Masoud, Bafrani Melika Arab, Gheysari Avesta, Sabetghadam Farideh, Ahmadi Mehdi, Sadeghi Mohammad, Mayeli Mahsa
School of Medicine, North Khorasan University of Medical Sciences, North Khorasan, Iran.
Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Clin Park Relat Disord. 2025 Apr 18;12:100331. doi: 10.1016/j.prdoa.2025.100331. eCollection 2025.
Determining Parkinson's disease (PD) stage and severity are among the factors affecting treatment strategy. Dopamine transporter scan (DaTSCAN) has high efficiency in the diagnosis of PD, while its role in predicting motor function, dyskinesia, and symptoms severity trajectory remains controversial. This study aimed to evaluate the associations between motor symptoms patterns in PD with DaTscan findings.
A total of 196 patients were included and grouped based on tremor score, postural instability and gait difficulty score, and the presentation of dyskinesia. Multivariate and ordinal logistic regression models were used to investigate the association between two-year follow-up of the PD patients' motor symptoms assessment scores and DaTSCAN finding patterns.
Patients with dyskinesia exhibited significantly lower DaTSCAN uptake across all measured regions, with the most pronounced reductions observed in the right caudate and left putamen (p < 0.001). Additionally, DaTSCAN values were strongly associated with overall disease severity (p < 0.001). A notable positive correlation was found between DaTSCAN uptake and Schwab and England Activities of Daily Living (ADL) scores, whereas significant negative correlations were observed between DaTSCAN measures (including the caudate, putamen, and anterior putamen) and clinical motor scores, such as MDS-UPDRS III, MDS-UPDRS II, and PIGD. In contrast, DaTSCAN parameters did not significantly predict tremor-dominant (TD) scores.
Beyond its diagnostic utility, DaTSCAN provides meaningful insights into disease severity and motor dysfunction in PD, with particular relevance to postural instability and gait disturbance.
确定帕金森病(PD)的阶段和严重程度是影响治疗策略的因素之一。多巴胺转运体扫描(DaTSCAN)在PD诊断中具有较高效率,但其在预测运动功能、异动症和症状严重程度轨迹方面的作用仍存在争议。本研究旨在评估PD患者运动症状模式与DaTscan结果之间的关联。
共纳入196例患者,并根据震颤评分、姿势不稳和步态困难评分以及异动症表现进行分组。使用多变量和有序逻辑回归模型研究PD患者运动症状评估评分的两年随访结果与DaTSCAN结果模式之间的关联。
出现异动症的患者在所有测量区域的DaTSCAN摄取均显著降低,右侧尾状核和左侧壳核的降低最为明显(p < 0.001)。此外,DaTSCAN值与整体疾病严重程度密切相关(p < 0.001)。发现DaTSCAN摄取与施瓦布和英格兰日常生活活动(ADL)评分之间存在显著正相关,而在DaTSCAN测量值(包括尾状核、壳核和壳核前部)与临床运动评分(如MDS-UPDRS III、MDS-UPDRS II和PIGD)之间观察到显著负相关。相比之下,DaTSCAN参数不能显著预测震颤为主型(TD)评分。
除了其诊断效用外,DaTSCAN还能为PD的疾病严重程度和运动功能障碍提供有意义的见解,尤其与姿势不稳和步态障碍相关。